Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Treatment of malignant gastroduodenal obstruction with a nitinol self-expanding metal stent: An international prospective multicentre registry
Digestive and Liver Disease, Volume 44, No. 1, Year 2012
Notification
URL copied to clipboard!
Description
Background: Duodenal stenting has become a broadly accepted first line of treatment for patients with advanced malignant gastroduodenal obstruction as these patients are difficult to treat and are poor surgical candidates. Aims: To document duodenal stent performance for palliative management of malignant gastroduodenal obstruction. Methods: Multicentre, single arm, prospective registry documenting peroral endoscopic duodenal stenting procedures in 202 patients. Results: Technical success achieved in 98% (CI, 95%, 99%) of stent placements. Increase of Gastric Outlet Obstruction Score by at least 1 point compared to baseline was achieved in 91% (CI, 86%, 95%) of patients persisting for a median of 184 days (CI, 109, 266). By day 5 (CI, 4, 6) after stent placement, 50% of patients experienced a score increase of at least 1 point.Improvement from 14% of patients at baseline tolerating soft solids or low residue/normal diet to 84% at 15 days, 86% at 30 days, 81% at 90 days, 79% at 180 days, and 70% at 270 days. Complications included stent ingrowth and/or overgrowth (12.4%), transient periprocedural symptoms (3%), bleeding (3%), stent migration (1.5%), and perforation (0.5%). Conclusions: Safety and effectiveness of duodenal stenting for palliation of malignant gastroduodenal obstruction was confirmed in the largest international prospective series to date. © 2011 Editrice Gastroenterologica Italiana S.r.l..
Authors & Co-Authors
Costamagna, Guido
Italy, Rome
Fondazione Policlinico Universitario Agostino Gemelli Irccs
Tringali, A.
Italy, Rome
Fondazione Policlinico Universitario Agostino Gemelli Irccs
Spicak, Julius
Czech Republic, Prague
Institutu Klinické a Experimentální Medicíny
MUTIGNANI, Massimiliano
Italy, Rome
Fondazione Policlinico Universitario Agostino Gemelli Irccs
Shaw, John M.
South Africa, Observatory
Groote Schuur Hospital
Roy, Andre F.
Canada, Montreal
Centre Hospitalier de L'universite de Montreal
Johnsson, Erik
Sweden, Gothenburg
Sahlgrenska Universitetssjukhuset
De Moura, Eduardo G.H.
Brazil, Sao Paulo
Universidade de São Paulo
Cheng, Spencer
Brazil, Sao Paulo
Universidade de São Paulo
Ponchon, Thierry
France, Lyon
Hopital Edouard Herriot
Bittinger, Max
Germany, Augsburg
Klinikum Augsburg
Messmann, Helmut
Germany, Augsburg
Klinikum Augsburg
Neuhaus, Horst N.
Germany, Dusseldorf
Evangelisches Krankenhaus Düsseldorf
Schumacher, Brigitte
Germany, Dusseldorf
Evangelisches Krankenhaus Düsseldorf
Laugier, René
France, Marseille
Hopital la Timone
Saarnio, Juha
Finland, Oulu
Oulu University Hospital
Ariqueta, Francisco Igea
Spain, Palencia
Hospital Universitario Río Carrión
Statistics
Citations: 75
Authors: 17
Affiliations: 12
Identifiers
Doi:
10.1016/j.dld.2011.08.012
ISSN:
15908658
e-ISSN:
18783562
Research Areas
Cancer
Health System And Policy
Study Design
Cohort Study